Week in Review

Font Size:

FDA widens meningitis drug warnings, CFPB pursues rules on reverse mortgages, and more.

Font Size:
  • The Food and Drug Administration (FDA) warned patients and physicians that the drug company connected to the meningitis outbreak may be linked to new reports of contamination.
  • Tension intensified between FTC regulators and the advertising industry over the proper limits of online tracking.
  • The SEC proposed new swap rules and invited public comments.
  • Various regulators from around the world expressed concerns about Google’s privacy policy, but the U.S. FTC opted not to join.
  • Industry group claimed that newly minted U.S. regulations have slowed the rate of derivatives trading across Asia.